FibroGen To Present Data From Dose Escalation Phase 1b Study of FG-3246 Plus Enzalutamide At 2024 American Society of Clinical Oncology Annual Meeting May 31-Jun. 4
FibroGen 將在 5 月 31 日至 6 月 31 日的 2024 年美國臨床腫瘤學會年會上公佈 FG-3246 Plus Enzalutamide 1b 期劑量遞增研究的數據。4